Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome-2
- Vincent Vuaroqueaux (68049)
- Patrick Urban (68053)
- Martin Labuhn (68051)
- Mauro Delorenzi (13915)
- Pratyaksha Wirapati (25520)
- Christopher C Benz (62343)
- Renata Flury (77218)
- Holger Dieterich (77219)
- Frédérique Spyratos (77220)
- Urs Eppenberger (68054)
- Serenella Eppenberger-Castori (68056)
Publication date
December 2011
DOIAbstract
<p><b>Copyright information:</b></p><p>Taken from "Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome"</p><p>http://breast-cancer-research.com/content/9/3/R33</p><p>Breast Cancer Research 2007;9(3):R33-R33.</p><p>Published online 29 May 2007</p><p>PMCID:PMC1929097.</p><p></p>le) and the 70-gene signature, intrinsic subtypes, the recurrence score (Rsu), and the wound response signature. CI, 95% confidence interval; HR, hazard ratio
Add to ORKG